| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1097-0258(20001215)19:23<3251::AID-SIM625>3.0.CO;2-2 |
| P8608 | Fatcat ID | release_f6wfhofthbe4foakfeemuvo7k4 |
| P698 | PubMed publication ID | 11113958 |
| P2093 | author name string | Thompson SG | |
| Sharp SJ | |||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| P304 | page(s) | 3251-3274 | |
| P577 | publication date | 2000-12-01 | |
| P1433 | published in | Statistics in Medicine | Q7604438 |
| P1476 | title | Analysing the relationship between treatment effect and underlying risk in meta-analysis: comparison and development of approaches. | |
| P478 | volume | 19 |
| Q33261643 | 'Lost in translation': accounting for between-country differences in the analysis of multinational cost-effectiveness data |
| Q33305487 | A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity |
| Q48142451 | Accounting for baseline differences in meta-analysis |
| Q47789168 | Assessing the applicability of trial evidence to a target sample in the presence of heterogeneity of treatment effect |
| Q53021327 | Assessing the implications of publication bias for two popular estimates of between-study variance in meta-analysis. |
| Q92616693 | Assessing the relative efficacy of interleukin-17 and interleukin-23 targeted treatments for moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis of PASI response |
| Q40290263 | Bayesian evidence synthesis for exploring generalizability of treatment effects: a case study of combining randomized and non-randomized results in diabetes |
| Q36381197 | Bayesian methods for evidence synthesis in cost-effectiveness analysis |
| Q28756698 | Bench-to-bedside review: avoiding pitfalls in critical care meta-analysis--funnel plots, risk estimates, types of heterogeneity, baseline risk and the ecologic fallacy |
| Q38257403 | Comparative efficacy of biological treatments for moderate-to-severe psoriasis: a network meta-analysis adjusting for cross-trial differences in reference arm response |
| Q38935685 | Comparison of diagnostics for the detection of asymptomatic Plasmodium falciparum infections to inform control and elimination strategies. |
| Q35040678 | Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section. |
| Q44984775 | Detecting and adjusting for small-study effects in meta-analysis |
| Q38339691 | Do antipsychotics prevent postoperative delirium? A systematic review and meta-analysis |
| Q56940724 | Does treatment effect depend on control event rate? Revisiting a meta-analysis of suicidality and antidepressant use in children |
| Q38568527 | Effects of glucose-lowering and multifactorial interventions on cardiovascular and mortality outcomes: a meta-analysis of randomized control trials. |
| Q38032610 | Endotoxemia and mortality prediction in ICU and other settings: underlying risk and co-detection of gram negative bacteremia are confounders |
| Q33289230 | Explaining the heterogeneous scrapie surveillance figures across Europe: a meta-regression approach |
| Q37072917 | Exploring heterogeneity in meta-analyses: needs, resources and challenges |
| Q36503207 | Factors determining the occurrence of submicroscopic malaria infections and their relevance for control |
| Q43508915 | Generalized synthesis of evidence and the threat of dissemination bias. the example of electronic fetal heart rate monitoring (EFM). |
| Q36103365 | Infant sleeping position and the sudden infant death syndrome: systematic review of observational studies and historical review of recommendations from 1940 to 2002. |
| Q34356617 | Investigating clinical heterogeneity in systematic reviews: a methodologic review of guidance in the literature |
| Q37115919 | Meta-analysis methods |
| Q46881021 | Multiplicative interaction in network meta-analysis |
| Q37116846 | No role for initial severity on the efficacy of antidepressants: results of a multi-meta-analysis |
| Q51901659 | On statins, strokes, meta-analyses, competing risks, and the onward march of science. |
| Q35092973 | Osteoarthritis subpopulations and implications for clinical trial design |
| Q30829257 | Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis |
| Q34293900 | Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis |
| Q44508804 | The SIMEX approach to measurement error correction in meta-analysis with baseline risk as covariate. |
| Q44113835 | The use of two-way linear mixed models in multitreatment meta-analysis |
| Q36017145 | Treating individuals 4: can meta-analysis help target interventions at individuals most likely to benefit? |
| Q34153235 | Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective. |
| Q36801651 | Ursodeoxycholic acid for patients with primary biliary cirrhosis: an updated systematic review and meta-analysis of randomized clinical trials using Bayesian approach as sensitivity analyses |
| Q24241945 | Ursodeoxycholic acid for primary biliary cirrhosis |
| Q61853095 | Use of a random effects meta-analysis in the design and analysis of a new clinical trial |
| Q50577445 | Using network meta-analysis to evaluate the existence of small-study effects in a network of interventions. |
| Q34653391 | Why do clinicians sometimes find it difficult to use the results of systematic reviews in routine clinical practice? |
Search more.